HHS Awards $46 Million Contract for Atropine Autoinjectors to Strategic National Stockpile

The U.S. Department of Health and Human Services (HHS), through its Administration for Strategic Preparedness and Response (ASPR) and Strategic National Stockpile (SNS), has awarded a three-year, $46 million agreement to Rafa Laboratories. This contract is for the supply of Atropine Autoinjectors, crucial for reinforcing the nation's readiness to counteract chemical nerve-agent threats.